Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epothilone D in 2nd line NSCLC
NCT00080509Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Epothilone D in non-small cell lung cancer (NSCLC), sponsored by Bristol Myers Squibb. Started Dec 2003; status: terminated.
02
Drugs
Epothilone D
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00080509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080509.